Pediatric vitiligo.
Study Design
- Çalışma Türü
- Review
- Popülasyon
- Children with vitiligo
- Müdahale
- Pediatric vitiligo. None
- Karşılaştırıcı
- None
- Birincil Sonuç
- Pediatric vitiligo management
- Etki Yönü
- Positive
- Yanlılık Riski
- Unclear
Abstract
Vitiligo is a disease of pigment loss. Most investigators currently consider vitiligo to be a disorder that occurs as a result of autoimmune destruction of melanocytes, supported by identification of antimelanocyte antibodies in many patients, and the presence of comorbid autoimmune disease in patients with and family members of individuals with vitiligo. One-half of vitiligo cases are of childhood onset. This article presents a current overview of pediatric vitiligo including comorbidities of general health, psychological factors, therapeutic options, and long-term health considerations.
Kısaca
A current overview of pediatric vitiligo including comorbidities of general health, psychological factors, therapeutic options, and long-term health considerations is presented.
Used In Evidence Reviews
Similar Papers
Archives of internal medicine · 2009
Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey.
Journal of autoimmunity · 2019
Systemic lupus erythematosus: Diagnosis and clinical management.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2011
Vitamin D and the immune system.
Archives of disease in childhood · 2021
Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections.
Gastroenterology · 2010
Primary prevention of colorectal cancer.
Journal of cachexia, sarcopenia and muscle · 2020